BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3402591)

  • 1. Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden.
    Specht L; Nissen NI
    Eur J Haematol; 1988 Jul; 41(1):80-7. PubMed ID: 3402591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in Hodgkin's disease stage IV.
    Specht L; Nissen NI
    Eur J Haematol; 1988 Oct; 41(4):359-67. PubMed ID: 3197822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease and age.
    Specht L; Nissen NI
    Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Br J Cancer; 1987 May; 55(5):535-9. PubMed ID: 3300762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Cancer; 1988 Apr; 61(8):1719-27. PubMed ID: 3349432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
    Specht L; Nissen NI
    Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour burden as the main indicator of prognosis in Hodgkin's disease.
    Specht L
    Eur J Cancer; 1992; 28A(12):1982-5. PubMed ID: 1419295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
    Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination.
    Specht L; Nissen NI
    Eur J Haematol; 1988 May; 40(5):396-402. PubMed ID: 3378595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for positive surgical staging in patients with Hodgkin's disease.
    Mauch P; Larson D; Osteen R; Silver B; Yeap B; Canellos G; Weinstein H; Rosenthal D; Pinkus G; Jochelson M
    J Clin Oncol; 1990 Feb; 8(2):257-65. PubMed ID: 2299369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage I and II subdiaphragmatic Hodgkin's disease.
    Mai DH; Peschel RE; Portlock C; Knowlton A; Farber L
    Cancer; 1991 Oct; 68(7):1476-81. PubMed ID: 1893346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
    Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
    Specht L; Nissen NI; Walbom-Jørgensen S
    Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic substages of stage III-A Hodgkin's disease. A collaborative study.
    Stein RS; Golomb HM; Diggs CH; Mauch P; Hellman S; Wiernik PH; Ultmann JE; Rosenthal DS
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):159-65. PubMed ID: 7352720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.